Phase I Study of Erbitux and Velcade for Patints with Solid Tumors Expressing EGFR
|Effective start/end date||4/8/05 → 6/30/10|
- MILLENIUM PHARM
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.